Evidence map›Paper›PMID 32312250›Full record

ArticleBMC endocrine disorders2020

Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet.

Christoph Werner, Amelie Lupp, Gabriele Mtuka-Pardon, Christof Kloos, Gunter Wolf, René Aschenbach, Anika Biermann, Martin Freesmeyer, Philipp Seifert

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC endocrine disorders, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Christoph WernerClinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany. christoph.werner@med.uni-jena.de.ORCID https://orcid.org/0000-0002-7000-8118
Amelie LuppInstitute of Pharmacology and Toxicology, Jena University Hospital, Jena, Germany.ORCID https://orcid.org/0000-0003-0141-7310
Gabriele Mtuka-PardonClinic of General, Visceral and Vascular Surgery, Jena University Hospital, Jena, Germany.
Christof KloosClinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany.
Gunter WolfClinic of Internal Medicine III, Jena University Hospital, Am Klinikum 1, 07747, Jena, Thuringia, Germany.
René AschenbachDepartment of Radiology, Jena University Hospital, Jena, Germany.
Anika BiermannInstitute of Pathology, Jena University Hospital, Jena, Germany.
Martin FreesmeyerClinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.ORCID https://orcid.org/0000-0002-6462-3851
Philipp SeifertClinic of Nuclear Medicine, Jena University Hospital, Jena, Germany.ORCID https://orcid.org/0000-0002-3447-4971
Jena University Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrimary hyperparathyroidism is a rare condition of disease which can seldomly present as giant retrotrhyroideal cysts, complicating the localization of the adenoma to resect. CASE PRESENTATION: A 56-year old female presented with hypercalcaemia of 3.38 mmol/L (2.2-2.65 mmol/L) and a history of breast cancer. A fast growing cystic parathyroidal adenoma was diagnosed by a multimodal approach including comprehensive diagnostic imaging (ultrasonography, scintigraphies, dynamic MRI) and cytopathological investigations after ultrasonography-guided puncture. The patient was cured by surgical extraction of the whole adenoma. In retrospect, the rapid growth was most likely induced by cinacalcet (initially 30 mg/d, later 60 mg/d) therapy which the patient received for few months only. Primary hyperparathyroidism was ascertained because surgical removal of the solitary adenoma cured the patient. Furthermore, there was no relevant renal insufficiency or history of prolonged calcium-level deregulation.

conclusionsThis phenomenon of cystic degeneration of parathyroidal adenoma under therapy with cinacalcet has previously been described in secondary hyperparathyroidism, but not in primary hyperparathyroidism and should be considered in diagnostic approach.

Indexed as

AdenomaBiopsyCalcium-Regulating Hormones and AgentsCinacalcetCystsDiagnostic ErrorsDisease ProgressionFemaleHumansHypercalcemiaHyperparathyroidism, PrimaryMagnetic Resonance ImagingMiddle AgedParathyroid NeoplasmsRadionuclide ImagingThyroid DiseasesCalcium-Regulating Hormones and AgentsCinacalcetAdenomaCystHead and neckHyperparathyroidismParathyroid

Identifiers

PMID32312250
PMCPMC7171747
OpenAlexW3017389785

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.